These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32419049)

  • 1. Chewable Antacid Tablets: Are Disintegration Tests Relevant?
    Nyamweya NN; Kimani SN; Abuga KO
    AAPS PharmSciTech; 2020 May; 21(5):139. PubMed ID: 32419049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An index for evaluating difficulty of Chewing Index for chewable tablets.
    Gupta A; Chidambaram N; Khan MA
    Drug Dev Ind Pharm; 2015 Feb; 41(2):239-43. PubMed ID: 24252107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburn.
    Robinson M; Rodriguez-Stanley S; Miner PB; McGuire AJ; Fung K; Ciociola AA
    Aliment Pharmacol Ther; 2002 Mar; 16(3):435-43. PubMed ID: 11876696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models.
    Uebbing L; Klumpp L; Webster GK; Löbenberg R
    Drug Des Devel Ther; 2017; 11():1163-1174. PubMed ID: 28442890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation development of sugar free antacid chewable tablets for diabetes induced acidity in patients.
    Khan M; Rehman H; Ayaz S; Qamar F; Owais A; Sana A; Naveed S
    Pak J Pharm Sci; 2019 Nov; 32(6(Supplementary)):2811-2816. PubMed ID: 32024618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pH on in vitro disintegration of phosphate binders.
    Stamatakis MK; Alderman JM; Meyer-Stout PJ
    Am J Kidney Dis; 1998 Nov; 32(5):808-12. PubMed ID: 9820451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution testing of orally disintegrating tablets.
    Kraemer J; Gajendran J; Guillot A; Schichtel J; Tuereli A
    J Pharm Pharmacol; 2012 Jul; 64(7):911-8. PubMed ID: 22686339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effectiveness of a new antacid chewing gum on heartburn and oesophageal pH control.
    Collings KL; Rodriguez-Stanley S; Proskin HM; Robinson M; Miner PB
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2029-35. PubMed ID: 12452946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada.
    Walker AD; Adachi JD
    Curr Med Res Opin; 2011 Sep; 27(9):1749-54. PubMed ID: 21781014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
    Hooper P; Lasher J; Alexander KS; Baki G
    J Pharm Biomed Anal; 2016 Feb; 120():391-6. PubMed ID: 26774944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
    Lin MS; Sun P; Yu HY
    J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of intelligent tablets with an antacid effect.
    Bajdik J; Korbely A; Pintye-Hódi K
    Pharm Dev Technol; 2009; 14(5):471-5. PubMed ID: 19552554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K; Langguth P
    Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterion.
    Weda M; van Riet-Nales DA; van Aalst P; de Kaste D; Lekkerkerker JF
    Pharmeur Sci Notes; 2006 Dec; 2006(2):41-4. PubMed ID: 17691213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of magaldrate antacid efficacy in the presence of some drugs and its effect on their dissolution rates: Part I.
    al Gohary OM
    Boll Chim Farm; 1996 Dec; 135(11):621-37. PubMed ID: 9066172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumer vinegar test for determining calcium disintegration.
    Mason NA; Patel JD; Dressman JB; Shimp LA
    Am J Hosp Pharm; 1992 Sep; 49(9):2218-22. PubMed ID: 1524066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal ulcer healing with four antacid tablets daily.
    Weberg R; Berstad A; Lange O; Schultz T; Aubert E
    Scand J Gastroenterol; 1985 Nov; 20(9):1041-5. PubMed ID: 3911365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of compression forces on tablets disintegration by AC Biosusceptometry.
    Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the in vivo disintegration of solid dosage forms of a bile acid sequestrant in dogs using gamma-scintigraphy and correlation to in vitro disintegration.
    Hussain MA; Chang RK; Sandefer E; Page RC; Digenis GA
    Pharm Res; 2003 Mar; 20(3):460-4. PubMed ID: 12669969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
    Jung HA; Augsburger LL
    Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.